Cite
Antiproliferative treatment of myofibroblasts prevents arrhythmias in vitro by limiting myofibroblast-induced depolarization.
MLA
Askar, Saïd F. A., et al. “Antiproliferative Treatment of Myofibroblasts Prevents Arrhythmias in Vitro by Limiting Myofibroblast-Induced Depolarization.” Cardiovascular Research, vol. 90, no. 2, May 2011, pp. 295–304. EBSCOhost, https://doi.org/10.1093/cvr/cvr011.
APA
Askar, S. F. A., Ramkisoensing, A. A., Schalij, M. J., Bingen, B. O., Swildens, J., van der Laarse, A., Atsma, D. E., de Vries, A. A. F., Ypey, D. L., & Pijnappels, D. A. (2011). Antiproliferative treatment of myofibroblasts prevents arrhythmias in vitro by limiting myofibroblast-induced depolarization. Cardiovascular Research, 90(2), 295–304. https://doi.org/10.1093/cvr/cvr011
Chicago
Askar, Saïd F.A., Arti A. Ramkisoensing, Martin J. Schalij, Brian O. Bingen, Jim Swildens, Arnoud van der Laarse, Douwe E. Atsma, Antoine A.F. de Vries, Dirk L. Ypey, and Daniël A. Pijnappels. 2011. “Antiproliferative Treatment of Myofibroblasts Prevents Arrhythmias in Vitro by Limiting Myofibroblast-Induced Depolarization.” Cardiovascular Research 90 (2): 295–304. doi:10.1093/cvr/cvr011.